Insight Molecular Diagnostics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $11.6M | $8.6M | $9.4M | $20.0M | $32.9M | $7.1M | $22.1M | $8.0M |
| Accounts Receivable | $1.1M | $1.6M | $484.0K | $2.0M | $1.4M | $203.0K | — | — |
| Inventory | $446.0K | $410.0K | — | — | — | — | — | — |
| Total Current Assets | $15.3M | $11.8M | $10.7M | $25.5M | $39.1M | $9.2M | $23.0M | $8.6M |
| Property, Plant & Equipment | $9.3M | $6.3M | $4.7M | $8.7M | $7.1M | $4.4M | $3.6M | $614.0K |
| Goodwill | — | — | — | — | $18.7M | $9.2M | — | — |
| Intangible Assets (Excl. Goodwill) | $0 | $14.6M | $56.6M | $61.6M | $61.7M | $15.0M | — | — |
| Total Assets | $25.8M | $35.1M | $74.9M | $100.1M | $159.6M | $55.4M | $39.9M | $9.5M |
| Liabilities | ||||||||
| Accounts Payable | $2.5M | $1.6M | $953.0K | $1.3M | $1.8M | $432.0K | $469.0K | $166.0K |
| Total Current Liabilities | $12.1M | $7.3M | $7.2M | $12.1M | $14.1M | $9.0M | $4.4M | $5.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $57.2M | $47.4M | $49.3M | $60.5M | $94.3M | $21.9M | $9.0M | $6.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-400.8M | $-350.5M | $-289.9M | $-260.7M | $-187.8M | $-123.7M | $-93.7M | $-71.3M |
| Total Stockholders' Equity | $-31.5M | $-12.3M | $20.5M | $34.3M | $65.2M | $33.5M | $30.8M | $3.4M |